Cost-effectiveness of oral treatments for chronic hepatitis B.
Dusheiko
Geoffrey M
GM
D000284:Administration, Oral; D000998:Antiviral Agents / Q000008:administration & dosage* / Q000191:economics*; D003362:Cost-Benefit Analysis; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000191:economics*; D006801:Humans; D018803:Models, Economic; D019057:Quality-Adjusted Life Years
D000998:Antiviral Agents